International IPOX® (Associated 5-star ETF: FPXI) strikes as state monopoly China Tobacco International (6055 HK) rallies +371.91% since June 12 IPO!
IPOX Schuster LLC, the Financial Services Firms behind an array of innovative investment solutions including the IPOX® Indexes, is pleased to note a fresh year-high in its International IPOX® (IPXI).
On the back of big gains in portfolio holding ESG-free June 12, 2019 IPO consumer staple China Tobacco International (HK) (6055 HK: +51.83%), the portfolio added +1.36% to +20.36% YTD, a fresh yearly high.
Composed of a diversified basket of non-U.S. domiciled firms, the International IPOX ® (IPXI) provides exposure to 50 of the largest and best performing respective New Listings by applying the IPOX® Portfolio Technology. Current constituents include high-caliber firms such Italian luxury car maker Ferrari (RACE IM), the world’s leading windfarm operator Denmark’s Orsted (ORSTED DC) or aforementioned consumer staple state monopoly China Tobacco International (HK) (6055 HK), one of the most successful New Listings in Hong Kong in recent history.
Exposure to the International IPOX® (IPXI) is available via a number of Financial products, including the First Trust International Equity Opportunities Fund (FPXI), the NASDAQ-listed Exchange-Traded-Fund (ETF). Over the past three years, FPXI has produced a total return of +55.14% vs. +30.21% for the Vanguard Total International Stock ETF (VXUS), a performance difference of a massive +656 bps. p.a. in favor of IPOX. The Fund is ranked on top of the U.S.-traded International Equity ETF category, achieving a 5-star (3-year) rating from Morningstar (MORN), a rating firm.
FPXI is the sister fund to the USD billion 1.2, 5-star U.S. IPOX (IPXO) linked NYSE-listed First Trust U.S. Equity Opportunities ETF (FPX), which focuses on New Listings domiciled and trading in the United States.
For further information, please contact us using the co-ordinates below. Thank you.
The IPOX Team
IPOX Schuster LLC
Dr. Josef Schuster, PM
225 West Washington, Suite 400
Chicago, IL 60606
(312) 827-3681 (office)
(312) 339-4114 (cell)